HHS Expects Up To $614 Per Dose Savings For Seniors Due To IRA Inflation Rebate Policy

CMS anticipates that seniors taking select Medicare Part B drugs will save up to $614 per dose in coinsurance beginning Oct. 1 as a result of manufacturers having to pay the government rebates because their prices increased faster than inflation. CMS on Wednesday (Sept. 13) announced manufacturers of 34 Part B drugs will need to pay the inflationary rebates put in place by the Inflation Reduction Act. The list includes drugs manufactured by Johnson & Johnson’s Jassen, AbbVie, Amgen and...